The DONNA Foundation is proud to partner with Puma Biotechnology to present a FREE, early stage HER2+ Breast Cancer patient education webinar in conjunction with our AARP DONNA Mother’s Day Your Way event.

Thursday, May 6, 2021
12:00 PM CT | 1:00 PM ET
Event Invitation Flyer (PDF)

Please visit to register for this FREE program.

With so many events being cancelled or postponed due to the COVID-19 pandemic, it is even more critical for us to find ways to help patients continue to learn about their cancer, available treatment options, and how to advocate for themselves.

Puma Biotechnology has created a virtual solution to help fill this gap. On May 6th, Pat Washington, RN, OCN, PhD will facilitate a live webinar for patients with early stage HER2+ breast cancer with information about HER2-positivity, how NERYLNX works, side effect management, and self-advocacy. Patients will have an opportunity to ask questions and we can also provide webinar attendees with a PDF handout, “Questions to Ask Your Healthcare Provider.”

Please click the following link for more information and to register.

NERLYNX is a prescription medicine used alone to treat adults with early-stage human epidermal growth factor receptor (HER2)-positive breast cancer and who have previously been treated with trastuzumab-based therapy. It is not known if NERLYNX is safe and effective in children. Learn more about the NERLYNX Experience »


The most serious risks of NERLYNX are diarrhea and liver problems. NERLYNX can also harm your unborn baby. You should use effective birth control during treatment and for at least one month after your last dose of NERLYNX.

The most common side effects of NERLYNX when used alone include: diarrhea; nausea; stomach-area (abdomen) pain; tiredness; vomiting; rash; dry or inflamed mouth, or mouth sores; decreased appetite; muscle spasms; upset stomach; nail problems including color change; dry skin; swelling of your stomach-area; nosebleed; weight loss; urinary tract infection.

For additional IMPORTANT SAFETY INFORMATION and Patient Information about NERLYNX, please click the following link:

The DONNA Foundation does not endorse or recommend any commercial products, processes, or services. Therefore, mention of commercial products, processes, or services on any Foundation Web sites cannot be construed as an endorsement or recommendation.